Adrenaline Injection 0.1% Syringe 1mg/1mL (Adrenaline Injection 0.1% Syringe Terumo® / アドレナリン注0.1%シリンジ「テルモ」)

JPY ¥4,800

Japanese Adrenaline Preparation (Adrenaline 1mg/1mL). Prefilled syringe for subcutaneous, intramuscular, or intravenous injection; indicated for bronchospasm relief, acute hypotension/shock, and cardiac arrest. 1 mL syringe x 10 units [with oxygen absorber]. Mfd. by Terumo Corporation, Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥4,416
10 - 19 12% JPY ¥4,224
20 + 18% JPY ¥3,936
SKU: ADR-1-INJ Category:

Description

Product Overview / 商品概要

Adrenaline Injection 0.1% Syringe “Terumo” (アドレナリン注0.1%シリンジ「テルモ」)
Generic: Adrenaline / アドレナリン
Therapeutic Category: Adrenaline Preparation / アドレナリン製剤
Manufactured by: Terumo Corporation / テルモ株式会社

Composition & Specification / 組成・規格

Active Ingredient: Adrenaline 1mg per 1mL syringe / 1シリンジ1mL中 アドレナリン 1mg
Additives: Dilute hydrochloric acid (solubilizer) 3.9 μL, Sodium chloride (tonicity agent) 8.5 mg, Sodium hydrogen sulfite (stabilizer) 0.5 mg, Chlorobutanol (preservative) 3 mg, Sodium hydroxide (pH adjuster) q.s. / 希塩酸(溶解剤)3.9μL、塩化ナトリウム(等張化剤)8.5mg、亜硫酸水素ナトリウム(安定剤)0.5mg、クロロブタノール(保存剤)3mg、水酸化ナトリウム(pH調節剤)適量
Appearance: Clear, colorless solution. Gradually turns slightly red and then brown upon exposure to air or light. pH 2.3–5.0; osmolality ratio approximately 1 (relative to normal saline).
外観: 無色澄明の液。空気又は光によって徐々に微赤色となり、次に褐色となる。pH 2.3~5.0、浸透圧比 約1(生理食塩液に対する比)

Indications / 効能効果

EN: Relief of bronchospasm due to the following conditions: bronchial asthma, whooping cough / Adjunctive treatment of acute hypotension or shock associated with various diseases or conditions / Adjunctive treatment of cardiac arrest
JA: 下記疾患に基づく気管支痙攣の緩解:気管支喘息、百日咳/各種疾患もしくは状態に伴う急性低血圧またはショック時の補助治療/心停止の補助治療

Dosage and Administration / 用法用量

EN: For relief of bronchospasm due to bronchial asthma and whooping cough, adjunctive treatment of acute hypotension or shock, and adjunctive treatment of cardiac arrest: The usual adult dose is 0.2–1 mg (0.2–1 mL) of adrenaline administered subcutaneously or intramuscularly. Adjust dose as appropriate based on age and symptoms. In emergencies such as resuscitation, administer no more than 0.25 mg (0.25 mL) of adrenaline diluted in normal saline or similar solution by slow intravenous injection. Repeat every 5–15 minutes as necessary.
JA: 〈気管支喘息および百日咳に基づく気管支痙攣の緩解、各種疾患もしくは状態に伴う急性低血圧またはショック時の補助治療、心停止の補助治療〉アドレナリンとして、通常成人1回0.2~1mg(0.2~1mL)を皮下注射または筋肉内注射する。なお、年齢、症状により適宜増減する。蘇生などの緊急時には、アドレナリンとして、通常成人1回0.25mg(0.25mL)を超えない量を生理食塩液などで希釈し、できるだけゆっくりと静注する。なお、必要があれば、5~15分ごとにくりかえす。

Contraindications / 禁忌

EN: 2.1 Patients receiving antipsychotic drugs (butyrophenone-type, phenothiazine-type, etc.) or alpha-blockers (except in emergency treatment of anaphylactic shock). / 2.2 Patients receiving catecholamine preparations such as isoprenaline hydrochloride or noradrenaline, or adrenergic agonists (except in emergencies such as resuscitation).
JA: 2.1 ブチロフェノン系・フェノチアジン系等の抗精神病薬、α遮断薬を投与中の患者(ただし、アナフィラキシーショックの救急治療時はこの限りでない。)/2.2 イソプレナリン塩酸塩、ノルアドレナリン等のカテコールアミン製剤、アドレナリン作動薬を投与中の患者(ただし、蘇生等の緊急時はこの限りでない。)

Regulatory Information / 規制情報

Approval No.: 22100AMX00614
Sales Started: December 2000 / 2000年12月
Classification Code: 872451
Storage: Store at room temperature, protected from light / 遮光・室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 1 mL syringe x 10 units [with oxygen absorber] / 1mLシリンジ×10本[脱酸素剤入り]
Other Available Packages (by special order): 1 mL syringe x 10 units [with oxygen absorber]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Adrenaline Injection 0.1% Syringe 1mg/1mL (Adrenaline Injection 0.1% Syringe Terumo® / アドレナリン注0.1%シリンジ「テルモ」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Adrenaline Injection 0.1% Syringe 1mg

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.